A. R. Norman

Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study

Jervoise Andreyev, A. R. Norman, David Cunningham et al. · British Journal of Cancer · 2001 · 204 citations · Full text

Randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric (OG) cancer: The REAL 2 trial

David Cunningham, Sujaya Rao, Naureen Starling et al. · Journal of Clinical Oncology · 2006 · 108 citations

Gastrointestinal Oncology, Medicine, Metronomic Therapy +12

Clinically occult avascular necrosis of the hip in systemic lupus erythematosus.

Cynthia Aranow, Steven B. Zelicof, Denise Leslie et al. · PubMed · 1997 · 60 citations

randomised, multicenter phase-iii study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer: Confirmation of dose escalation : 1031

Kate Sumpter, Catherine Harper‐Wynne, David Cunningham et al. · 2003 · 25 citations

Dose Escalation, Gastrointestinal Oncology, Medicine +9

Cost of Illness and Health-Related Quality of Life for Stuttering: Two Systematic Reviews

A. R. Norman, Robyn Lowe, Mark Onslow et al. · Journal of Speech Language and Hearing Research · 2023 · 18 citations